Full Data
?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets
Join Now!
Need this critical market data?
Access thousands of market events, data points, and news articles!
Already have an account?
Login
Home » News » Orient Fortune Securities gave Xintian Pharmaceutical an overweight rating. Comments on the 2021 annual report: Forming a multi-gradient series of products and vigorously deploying the OTC market has achieved results.